CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer
2020 · International Journal of Molecular Sciences · 213 citations
https://doi.org/10.3390/ijms21186968
T
Takashi Ishikawa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
758
Papers
14.0K
Citations
57
h-index
279
i10-index
Takashi Ishikawa is an academic researcher from Tokyo Medical University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Gastric Cancer Management and Outcomes & Quantum Chromodynamics and Particle Interactions. The author has an h-index of 57, co-authored 645 publications.
ORCID: 0000-0003-3450-4533Papers by this author
worksPhase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
2017 · British Journal of Cancer · 107 citations
https://doi.org/10.1038/bjc.2017.144
Actionable gene-based classification toward precision medicine in gastric cancer
2017 · Genome Medicine · 91 citations
https://doi.org/10.1186/s13073-017-0484-3
The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer, 2015 edition
2016 · Breast Cancer · 88 citations
https://doi.org/10.1007/s12282-016-0670-y
Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate
2020 · Scientific Reports · 86 citations
https://doi.org/10.1038/s41598-020-58995-4
Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites
2002 · British Journal of Cancer · 85 citations
https://doi.org/10.1038/sj.bjc.6600580
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat